1. Home
  2. ACIU vs TAYD Comparison

ACIU vs TAYD Comparison

Compare ACIU & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.12

Market Cap

229.7M

Sector

Health Care

ML Signal

N/A

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

N/A

Current Price

$58.18

Market Cap

188.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACIU
TAYD
Founded
2003
1955
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
188.8M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ACIU
TAYD
Price
$2.12
$58.18
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $8.58
N/A
AVG Volume (30 Days)
★ 195.8K
24.2K
Earning Date
11-04-2026
12-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.14
Revenue
N/A
★ $41,649,673.00
Revenue This Year
$422.39
$25.09
Revenue Next Year
$377.85
$23.22
P/E Ratio
★ N/A
$417.00
Revenue Growth
★ N/A
N/A
52 Week Low
$2.02
$43.19
52 Week High
$3.90
$90.37

Technical Indicators

Market Signals
Indicator
ACIU
TAYD
Relative Strength Index (RSI) 41.11 52.19
Support Level $2.09 $51.63
Resistance Level $2.57 $59.69
Average True Range (ATR) 0.19 1.68
MACD -0.00 0.32
Stochastic Oscillator 18.69 64.53

Price Performance

Historical Comparison
ACIU
TAYD

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is engaged in the design, development, manufacture and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment and structures. The company continues to develop new and technology products. The company manufactures and sells a group of very similar products that have many different applications for customers. These similar products are included in one of nine categories, namely, Seismic Dampers, Fluidicshoks, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators. It has presence in USA, Asia, and Others. Majority of revenue comes from USA.

Share on Social Networks: